Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenneth Getz

Showing results (11-20 of 54) with videos related to

Pageof 6
Sort By:
Drug Information Journal|June 1, 2011
A New Mechanism for Tracking Publicly Available Study Volunteer DemographicsRachael Zuckerman, Kenneth Getz, Kenneth Kaitin
Therapeutic Innovation & Regulatory Science|February 3, 2020
Differences in Clinical Research Perceptions and Experiences by Age SubgroupAnnick Anderson, Deborah Borfitz, Kenneth Getz
JAMA Network Open|January 16, 2019
Global Public Attitudes About Clinical Research and Patient Experiences With Clinical TrialsAnnick Anderson, Deborah Borfitz, Kenneth Getz
Therapeutic Innovation & Regulatory Science|March 26, 2024
New Benchmarks on Protocol Amendment Experience in Oncology Clinical TrialsEmily Botto, Zachary Smith, Kenneth Getz
Therapeutic Innovation & Regulatory Science|June 7, 2021
Patient Engagement Initiatives in Clinical Trials: Recent Trends and ImplicationsShalome Sine, Annick de Bruin, Kenneth Getz
Therapeutic Innovation & Regulatory Science|September 21, 2018
Baseline Assessment of a Global Clinical Investigator Landscape Poised for Structural ChangeKenneth Getz, Carrie Brown, Stella Stergiopoulos, et al.
Therapeutic Innovation & Regulatory Science|January 30, 2022
Protocol Design Variables Highly Correlated with, and Predictive of, Clinical Trial PerformanceZachary Smith, Ralf Bilke, Sybrand Pretorius, et al.
Therapeutic Innovation & Regulatory Science|April 5, 2022
Benchmarking Protocol Deviations and Their Variation by Major Disease CategoriesKenneth Getz, Zachary Smith, Ananya Jain, et al.
Therapeutic Innovation & Regulatory Science|December 1, 2020
Assessing the Scope and Predictors of Intentional Dose Non-adherence in Clinical TrialsKenneth Getz, Zachary Smith, Laura Shafner, et al.
Therapeutic Innovation & Regulatory Science|June 8, 2025
Trends in the Burden for Patients Participating in Industry-Funded Clinical TrialsAbigail Dirks, Emily Botto, Zachary Smith, et al.
Pageof 6

Showing results (11-20 of 54) with videos related to

Sort By:
Pageof 6
Drug Information Journal|June 1, 2011
A New Mechanism for Tracking Publicly Available Study Volunteer DemographicsRachael Zuckerman, Kenneth Getz, Kenneth Kaitin
Therapeutic Innovation & Regulatory Science|February 3, 2020
Differences in Clinical Research Perceptions and Experiences by Age SubgroupAnnick Anderson, Deborah Borfitz, Kenneth Getz
JAMA Network Open|January 16, 2019
Global Public Attitudes About Clinical Research and Patient Experiences With Clinical TrialsAnnick Anderson, Deborah Borfitz, Kenneth Getz
Therapeutic Innovation & Regulatory Science|March 26, 2024
New Benchmarks on Protocol Amendment Experience in Oncology Clinical TrialsEmily Botto, Zachary Smith, Kenneth Getz
Therapeutic Innovation & Regulatory Science|June 7, 2021
Patient Engagement Initiatives in Clinical Trials: Recent Trends and ImplicationsShalome Sine, Annick de Bruin, Kenneth Getz
Therapeutic Innovation & Regulatory Science|September 21, 2018
Baseline Assessment of a Global Clinical Investigator Landscape Poised for Structural ChangeKenneth Getz, Carrie Brown, Stella Stergiopoulos, et al.
Therapeutic Innovation & Regulatory Science|January 30, 2022
Protocol Design Variables Highly Correlated with, and Predictive of, Clinical Trial PerformanceZachary Smith, Ralf Bilke, Sybrand Pretorius, et al.
Therapeutic Innovation & Regulatory Science|April 5, 2022
Benchmarking Protocol Deviations and Their Variation by Major Disease CategoriesKenneth Getz, Zachary Smith, Ananya Jain, et al.
Therapeutic Innovation & Regulatory Science|December 1, 2020
Assessing the Scope and Predictors of Intentional Dose Non-adherence in Clinical TrialsKenneth Getz, Zachary Smith, Laura Shafner, et al.
Therapeutic Innovation & Regulatory Science|June 8, 2025
Trends in the Burden for Patients Participating in Industry-Funded Clinical TrialsAbigail Dirks, Emily Botto, Zachary Smith, et al.
Pageof 6